International Patent: IMPROVING PRIME EDITING EFFICIENCY WITH CLINICALLY SAFE SMALL MOLECULES

GENEVA, Oct. 15 -- MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. filed a patent application (EP2025/059927) for “IMPROVING PRIME EDITING EFFICIENCY WITH CLINICALLY SAFE SMALL MOLECULES”. With publication no. WO/2026/214864, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/4706

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....